Keyword

G207

Description: A genetically engineered, conditionally replicating herpes simplex virus type 1 developed as an oncolytic therapy for cancer.
OpenAlex ID: keywords/g207
1995 · Toshihiro Mineta, Samuel D. Rabkin, et al. · Nature Medicine · 867
2008 · James M Markert, Peter G Liechty, et al. · Molecular Therapy · 433
2002 · Susan Varghese, Samuel D Rabkin · Cancer Gene Therapy · 297
2006 · Manish Aghi, Samuel Rabkin, et al. · JNCI Journal of the National Cancer Institute · 154
2002 · Joseph J Bennett, Keith A Delman, et al. · Cancer Gene Therapy · 100
2018 · Wenqing Ma, Hongbin He, et al. · BMC Immunology · 97
2000 · Keith A. Delman, Joseph J. Bennett, et al. · Human Gene Therapy · 93
2005 · Hideki Kasuya, Shin Takeda, et al. · Cancer Gene Therapy · 87
2000 · Priscilla F. McAuliffe, William R. Jarnagin, et al. · Journal of Gastrointestinal Surgery · 84
Works count: 114
Citation count: 7,459
Year
Topic
Type